Bacterial Ano-rectitis Sexually Transmitted in a Specialized Consultation Center

Ano-Rectal Infection Bacterial Nos Clinical Trial

— IST  

Official title:

Epidemiological, Clinical, Microbiological and Therapeutic Aspects of Sexually Transmitted Bacterial Ano-rectitis in a Specialized Consultation Center

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03625713
• Other study ID #: IST
• Status: Recruiting
• Start date: January 20, 2018
• Est. completion date: December 31, 2024

Study information

• Verified date: April 2023
• Source: Groupe Hospitalier Paris Saint Joseph
• Contact: Vincent De Parades, MD
• Phone: 0144127469
• Email: vdeparades[@]hpsj.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Infectious ano-rectitis is poorly described. Their epidemiology is poorly known, as are their clinical, diagnostic (diagnoses are regularly corrected in gastroenterology and new diagnostic tools are now available) and therapeutic aspects.

Analysis of data from this large population of patients referred to the proctology center for suspicion of Neisseria gonorrhoeae and / or Chlamydia trachomatis ano-rectitis will help identify risk factors and target prevention strategies and optimized therapeutic management.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 600
• Est. completion date: December 31, 2024
• Est. primary completion date: June 2, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient over the age of 18

• Patient consulting or hospitalized in the proctology center

• Patient for whom an anorectal sampling will be performed for suspicion of sexually transmitted infectious ano-rectitis

Exclusion Criteria:

• Patient's opposition to participate

• Patient deprived of liberty

• Patient under guardianship

Related Conditions & MeSH terms

• Ano-Rectal Infection Bacterial Nos
• Bacterial Infections

Locations

Country	Name	City	State
France	Groupe Hospitalier Paris Saint-Joseph	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Groupe Hospitalier Paris Saint Joseph

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluate the clinical presentation	Prevalence of clinical signs : fever (yes/no), ulcerations (yes/no), purulent proctisis (yes/no), erythematosus proctisis (yes/no), condyloma (yes/no)	Day 1